Robert L. Hoffman
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
-
- Computational Drug Discovery Methods
Papers in
-
- Synthesis and biological activity 5
- Synthesis and pharmacology of benzodiazepine derivatives 2
-
- Neurotransmitter Receptor Influence on Behavior 3
- Co-authors
- Kevin D. Freeman‐Cook (2 shared papers)Ted W. Johnson (1 shared paper)Michael D. Ennis (8 shared papers)Nabil B. Ghazal (7 shared papers)David W. Old (1 shared paper)Wha Bin Im (2 shared papers)Jeffrey F. Pregenzer (2 shared papers)Christopher S. Knauer (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)The Journal of Organic Chemistry (1 paper)Nature Communications (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesSweden
In The Last Decade
Robert L. Hoffman
18 papers receiving 1.8k citations
Robert L. Hoffman's Hit Papers
Peers
Comparison fields: 5 of 73
- Infectious Diseases 501
- Computational Theory and Mathematics 354
- Pulmonary and Respiratory Medicine 440
- Organic Chemistry 382
- Cancer Research 66
Countries citing papers authored by Robert L. Hoffman
This map shows the geographic impact of Robert L. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Hoffman more than expected).
Fields of papers citing papers by Robert L. Hoffman
This network shows the impact of papers produced by Robert L. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Hoffman. The network helps show where Robert L. Hoffman may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of (10 R )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- 2H -8,4-(metheno)pyrazolo[4,3- h ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations Hit paper breakdown → | 2014 | 495 |
| 2 | 2020 | 402 | |
| 3 | 2021 | 237 | |
| 4 | 2021 | 145 | |
| 5 | 2013 | 116 | |
| 6 | 2014 | 105 | |
| 7 | 2021 | 97 | |
| 8 | 1998 | 71 | |
| 9 | 1996 | 65 | |
| 10 | 1999 | 39 | |
| 11 | 2007 | 39 | |
| 12 | 2015 | 32 | |
| 13 | 2003 | 28 | |
| 14 | 1995 | 13 | |
| 15 | 1995 | 9 | |
| 16 | 1994 | 5 | |
| 17 | 1993 | 3 | |
| 18 | 2023 | 3 |
About Robert L. Hoffman
Robert L. Hoffman is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience, Computational Theory and Mathematics, Pulmonary and Respiratory Medicine and Psychiatry and Mental health, having authored 18 papers that have together received 1.9k indexed citations. Recurring topics across this work include Synthesis and biological activity (5 papers), Computational Drug Discovery Methods (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Receptor Mechanisms and Signaling (2 papers), Lung Cancer Treatments and Mutations (2 papers), Migraine and Headache Studies (2 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Infectious Diseases (501 citations), Computational Theory and Mathematics (354 citations), Pulmonary and Respiratory Medicine (440 citations), Organic Chemistry (382 citations) and Cancer Research (66 citations). Robert L. Hoffman has collaborated with scholars based in United States and Sweden. Frequent co-authors include Kevin D. Freeman‐Cook, Ted W. Johnson, Michael D. Ennis, Nabil B. Ghazal, David W. Old, Wha Bin Im, Jeffrey F. Pregenzer, Christopher S. Knauer, Lawrence W. Fitzgerald and Kjell A. Svensson. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, The Journal of Organic Chemistry, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.